Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedCore content removed: the study's condition 'Multiple Myeloma' and the related topic 'MedlinePlus Genetics' are no longer displayed on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedPublications section now states that PubMed publications are automatically filled from PubMed, and the page revision is updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check31 days agoChange DetectedRemoved the government funding status notice from the page; the study details and other information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check45 days agoChange DetectedThe new screenshot mirrors the prior version, with only minor layout adjustments and no changes to core study details such as title, conditions, interventions, primary outcomes, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedRelated topics updated to include Multiple Myeloma and MedlinePlus Genetics; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference0.9%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.